Approval · Notice of Compliance 76 · 2003
AMPHOTEC: Notice of Compliance 76
Issued June 11, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 76
- Date
- June 11, 2003
- Company
- Intermune, Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antifungal agent
Products in this notice
Medicinal ingredients
- AMPHOTERICIN B 50 MG per VIAL
- AMPHOTERICIN B 100 MG per VIAL